15,345
Views
15
CrossRef citations to date
0
Altmetric
Signature Reviews

Pathogenicity and virulence of Mycobacterium tuberculosis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2150449 | Received 18 Nov 2021, Accepted 17 Nov 2022, Published online: 04 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kangpeng Li, Bo Liu & Qiang Zhang. (2023) Recurrent Spinal Tuberculosis with HIV Infection After Surgery: A Rare Case of Recurrence and Drug Resistance. Infection and Drug Resistance 16, pages 7827-7833.
Read now
Tonino Alonzi, Federica Repele & Delia Goletti. (2023) Research tests for the diagnosis of tuberculosis infection. Expert Review of Molecular Diagnostics 23:9, pages 783-795.
Read now

Articles from other publishers (13)

Shamsi Yari, Parviz Afrough, Fatemeh Yari, Morteza Ghazanfari Jajin, Abolfazl Fateh & Alireza Hadizadeh Tasbiti. (2023) A potent subset of Mycobacterium tuberculosis glycoproteins as relevant candidates for vaccine and therapeutic target. Scientific Reports 13:1.
Crossref
Yang-yang TANG, Ying-ying CUI, Yan-yan JIANG, Ming-zhu SHAO, Xin-xin ZANG, Guang-hui DANG & Si-guo LIU. (2023) Characteristics of Mycobacterium tuberculosis serine protease Rv1043c in enzymology and pathogenicity in mice. Journal of Integrative Agriculture 22:12, pages 3755-3768.
Crossref
Yanchun Guan, Xiao Ma, Xiangnan Sun & Hongfeng Zhang. (2023) Metagenomic next-generation sequencing on bronchoalveolar lavage fluid to contribute to diagnosis of subclinical pulmonary tuberculosis with scarce sputum and negative smear in a patient mimicking adult- onset Still's disease: a case report. Diagnostic Microbiology and Infectious Disease, pages 116165.
Crossref
Sergio Lacámara & Carlos Martin. (2023) MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention. Archivos de Bronconeumología 59:12, pages 821-828.
Crossref
Joaquin Miguel Pellegrini, María Paula Morelli, María Isabel Colombo & Verónica Edith García. (2023) Editorial: Beneficial and detrimental host cellular responses against Mycobacterium tuberculosis infection. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Dulce Mata-Espinosa, Jacqueline V. Lara-Espinosa, Jorge Barrios-Payán & Rogelio Hernández-Pando. (2023) The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis. Pharmaceuticals 16:10, pages 1475.
Crossref
Jiahui Pan, Zecheng Chang, Xinyue Zhang, Qinzhou Dong, He Zhao, Jingwei Shi & Guoqing Wang. (2023) Research progress of single-cell sequencing in tuberculosis. Frontiers in Immunology 14.
Crossref
Vojo Deretic. (2023) Atg8ylation as a host-protective mechanism against Mycobacterium tuberculosis. Frontiers in Tuberculosis 1.
Crossref
Dong Wang, Yuanming Zou, Xinyue Huang, Zeyu Yin, Mohan Li, Jiaqi Xu, Boquan Wu, Da Li, Ying Zhang, Yingxian Sun, Xingang Zhang & Naijin Zhang. (2023) The role of SMURFs in non‐cancerous diseases . The FASEB Journal 37:8.
Crossref
Rita Capela, Rita Félix, Marta Clariano, Diogo Nunes, Maria de Jesus Perry & Francisca Lopes. (2023) Target Identification in Anti-Tuberculosis Drug Discovery. International Journal of Molecular Sciences 24:13, pages 10482.
Crossref
Lucero A. Ramon-Luing, Yadira Palacios, Andy Ruiz, Norma A. Téllez-Navarrete & Leslie Chavez-Galan. (2023) Virulence Factors of Mycobacterium tuberculosis as Modulators of Cell Death Mechanisms. Pathogens 12:6, pages 839.
Crossref
Kangling Zhang, Mark L. Sowers, Ellie I. Cherryhomes, Vipul K. Singh, Abhishek Mishra, Blanca I. Restrepo, Arshad Khan & Chinnaswamy Jagannath. (2023) Sirtuin-dependent metabolic and epigenetic regulation of macrophages during tuberculosis. Frontiers in Immunology 14.
Crossref
锐 肖. (2023) New Advances in the Characteristics and Di-agnosis of Mycobacterium tuberculosis. Advances in Clinical Medicine 13:08, pages 12489-12496.
Crossref